Item 8.01 Other Events. On April 15, 2020, Gene
Post# of 36533
(Total Views: 325)
Posted On: 06/23/2020 9:01:45 AM
Item 8.01 Other Events.
On April 15, 2020, Generex Biotechnology Corporation (“Generex”) received a letter of support from DiGiovanna Institute for Medical Education & Research, regarding Generex’s efforts to develop Generex’s li-Key-SARS-CoV-2 peptide vaccine with the goal to begin mass vaccination in the Fall of 2020. A copy of the letter of support is attached to this report as Exhibit 99.1 and is incorporated by reference herein.
About DiGiovanna Institute
The DiGiovanna Institute for Medical Education & Research was established in 1990. Dr. Michael J. DiGiovanna D.O., CPI incorporated the Institute as part of the DiGiovanna Family Health and Wellness Center in order to bring patients of the Center as well as members of the community the latest medical advances in a wide variety of indications. Dr. DiGiovanna has received his advanced certification as a Certified Principal Investigator from the Association of Clinical Research Professionals and the Academy of Physicians in Clinical Research.
Dr. DiGiovanna has participated in over 350 clinical investigations and worked with almost every major pharmaceutical company in the world, such as Pfizer, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Abbvie, Sanofi, Novo Nordisk, Amgen, Genentech, Roche, Bristol Meyers Squibb, and many others, as well as many smaller pharmaceutical companies.
On April 15, 2020, Generex Biotechnology Corporation (“Generex”) received a letter of support from DiGiovanna Institute for Medical Education & Research, regarding Generex’s efforts to develop Generex’s li-Key-SARS-CoV-2 peptide vaccine with the goal to begin mass vaccination in the Fall of 2020. A copy of the letter of support is attached to this report as Exhibit 99.1 and is incorporated by reference herein.
About DiGiovanna Institute
The DiGiovanna Institute for Medical Education & Research was established in 1990. Dr. Michael J. DiGiovanna D.O., CPI incorporated the Institute as part of the DiGiovanna Family Health and Wellness Center in order to bring patients of the Center as well as members of the community the latest medical advances in a wide variety of indications. Dr. DiGiovanna has received his advanced certification as a Certified Principal Investigator from the Association of Clinical Research Professionals and the Academy of Physicians in Clinical Research.
Dr. DiGiovanna has participated in over 350 clinical investigations and worked with almost every major pharmaceutical company in the world, such as Pfizer, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Abbvie, Sanofi, Novo Nordisk, Amgen, Genentech, Roche, Bristol Meyers Squibb, and many others, as well as many smaller pharmaceutical companies.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼